Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril vs Atenolol for Thoracic Aortic Aneurysm Expansion
NCT04224675Unknown
- Sponsor
- Onassis Cardiac Surgery Center
- Start
- Mar 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of captopril in thoracic aortic aneurysm (TAA) (2 arms), sponsored by Onassis Cardiac Surgery Center. Primary endpoint: Rate of change in the absolute diameter of the aortic root and ascending aorta at 36 months. Status: unknown.
02
Drugs
captopril
03
Conditions
thoracic aortic aneurysm (TAA)
Beyond the preview
Go deeper on NCT04224675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04224675.